To gain deeper insights into the role of TRIM26, we overexpressed it in prostate cancer cells (Fig. S3B, C) and subsequently evaluated its influence on evodiamine-induced inhibition of GPX4 protein expression. Here, TRIM26 is linked to prostate carcinoma.